Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort

Arthritis Research and Therapy

Volumn 11, Issue 4, 2009, Pages

  Gottenberg, Jacques Eric ^a   Miceli Richard, Corinne ^a   Ducot, Béatrice ^b   Goupille, Philippe ^c   Combe, Bernard ^d   Mariette, Xavier ^e  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d LAPEYRONIE HOSPITAL   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; BETA 2 MICROGLOBULIN; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; AUTOANTIBODY; BIOLOGICAL MARKER; TNFSF13B PROTEIN, HUMAN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DNA POLYMORPHISM; EROSION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; AGED; B LYMPHOCYTE; BLOOD; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED;

EID: 68649106906     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2773     Document Type: Article

References (32)

1. Martinez-Gamboa L Brezinschek HP Burmester GR Dorner T Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapy Autoimmun Rev 2006, 5:437-442. 10.1016/ j.autrev.2006.02.004 16920569
2. O'Neill SK Glant TT Finnegan A The role of B cells in animal models of rheumatoid arthritis Front Biosci 2007, 12:1722-1736. 10.2741/2184 17127417
3. Youinou P Jamin C Saraux A B-cell: A logical target for treatment of rheumatoid arthritis Clin Exp Rheumatol 2007, 25:318-328. 17543163
4. Eisenberg R Albert D B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus Nat Clin Pract Rheumatol 2006, 2:20-27. 10.1038/ncprheum0042 16932648
5. Rantapaa-Dahlqvist S de Jong BA Berglin E Hallmans G Wadell G Stenlund H Sundin U van Venrooij WJ Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum 2003, 48:2741-2749. 10.1002/art.11223 14558078
6. Nielen MM van Schaardenburg D Reesink HW Stadt van de RJ Horst-Bruinsma van der IE de Koning MH Habibuw MR Vandenbroucke JP Dijkmans BA Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors Arthritis Rheum 2004, 50:380-386. 10.1002/art.20018 14872479
7. Talal N Grey HM Zvaifler N Michalski JP Daniels TE Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis Science 1975, 187:1196-1198. 10.1126/science.46621 46621
8. Aho K Heliovaara M Knekt P Reunanen A Aromaa A Leino A Kurki P Heikkilä R Palosuo T Serum immunoglobulins and the risk of rheumatoid arthritis Ann Rheum Dis 1997, 56:351-356. 10.1136/ ard.56.6.351 1752401 9227163
9. Gottenberg JE Aucouturier F Goetz J Sordet C Jahn I Busson M Cayuela JM Sibili J Mariette X Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome Ann Rheum Dis 2007, 66:23-27. 10.1136/ard.2006.052159 16569685
10. Mackay F Schneider P Rennert P Browning J BAFF AND APRIL: A tutorial on B cell survival Annu Rev Immunol 2003, 21:231-264. 10.1146/ annurev.immunol.21.120601.141152 12427767
11. Combe B Benessiano J Berenbaum F Cantagrel A Daures JP Dougados M Fardellone P Fautrel B Flipo RM Goupolle P Guillemin F Le Loet X Logeart I Mariette X Meyer O Ravaud P Rincheval N Saraux A Schaeverbeke T Sibilia J The ESPOIR cohort: A ten-year follow-up of early arthritis in France: Methodology and baseline characteristics of the 813 included patients Joint Bone Spine 2007, 74:440-445. 10.1016/j.jbspin.2007.06.001 17905631
12. Emmerich F Bal G Barakat A Milz J Muhle C Martinez-Gamboa L Dörner T Salama A High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura Br J Haematol 2007, 136:309-314. 10.1111/j.1365-2141.2006.06431.x 17156395
13. Gottenberg JE Sellam J Ittah M Lavie F Proust A Zouali H Sordet C Sibilia J Kimberly RP Mariette X Miceli-Richard C No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome Arthritis Res Ther 2006, 8:R30. 10.1186/ar1884 1526574 16507129
14. Novak AJ Grote DM Ziesmer SC Kline MP Manske MK Slager S Witzig TE Shanafelt T Call TG Kay NE Jelinek DF Cerhan JR Gross JA Harder B Dillon SR Ansell SM Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders J Clin Oncol 2006, 24:983-987. 10.1200/JCO.2005.02.7938 16432079
15. Devauchelle-Pensec V Josseaume T Samjee I Dougados M Combe B Saraux A Ability of oblique foot radiographs to detect erosions in early arthritis: Results in the ESPOIR cohort Arthritis Rheum 2008, 59:1729-1734. 10.1002/art.24310 19035426
16. Lavie F Miceli-Richard C Ittah M Sellam J Gottenberg JE Mariette X Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: Insights into a new regulating system of BAFF production Ann Rheum Dis 2007, 66:700-703. 10.1136/ard.2006.060772 17040963
17. Vallerskog T Heimburger M Gunnarsson I Zhou W Wahren-Herlenius M Trollmo C Malström V Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis Arthritis Res Ther 2006, 8:R167. 10.1186/ar2076 1794511 17092341
18. Saraux A Berthelot JM Chales G Le Henaff C Thorel JB Hoang S Valls I Devauchelle V Martin A Baron D Pennec Y Botton E Mary JY Le Goff P Youinou P Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later Arthritis Rheum 2001, 44:2485-2491. 10.1002/ 1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S 11710704
19. Helm-van Mil Van der AHM le Cessie S van Dongen H Breedveld FC Toes REM Huizinga TWJ A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis Arthritis Rheum 2007, 56:433-440. 10.1002/art.22380 17265478
20. Symmons DP Silman AJ Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register Arthritis Res Ther 2006, 8:214. 1779379 16817941 10.1186/ar1979
21. Berglin E Johansson T Sundin U Jidell E Wadell G Hallmans G Rantapää-Dahlqvist S Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset Ann Rheum Dis 2006, 65:453-458. 10.1136/ard.2005.041376 1798112 16176994
22. Forslind K Ahlmén M Eberhardt K Hafström I Svensson B BARFOT Study Group Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: Role of antibodies to citrullinated peptides (anti-CCP) Ann Rheum Dis 2004, 63:1090-1095. 10.1136/ ard.2003.014233 1755129 15308518
23. Katzmann JA Clark RJ Abraham RS Bryant S Lymp JF Bradwell AR Kyle RA Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains Clin Chem 2002, 48:1437-1444. 12194920
24. Kawasaki A Tsuchiya N Fukazawa T Hashimoto H Tokunaga K Presence of four major haplotypes in human BCMA gene: Lack of association with systemic lupus erythematosus and rheumatoid arthritis Genes Immun 2001, 2:276-279. 10.1038/sj.gene.6363770 11528522
25. Cheema GS Roschke V Hilbert DM Stohl W Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases Arthritis Rheum 2001, 44:1313-1319. 10.1002/ 1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S 11407690
26. Collins CE Gavin AL Migone TS Hilbert DM Nemazee D Stohl W B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: Disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels Arthritis Res Ther 2006, 8:R6. 10.1186/ ar1855 1526545 16356193
27. Tan SM Xu D Roschke V Perry JW Arkfeld DG Ehresmann GR Migone TS Hilbert DM Stohl W Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis Arthritis Rheum 2003, 48:982-992. 10.1002/art.10860 12687540
28. Bosello S Youinou P Daridon C Tolusso B Bendaoud B Pietrapertosa D Morelli A Ferraccioli G Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis J Rheumatol 2008, 35:1256-1264. 18528969
29. Raza K Falciani F Curnow SJ Ross EJ Lee CY Akbar AN Lord JM Gordon C Buckley CD Salmon M Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin Arthritis Res Ther 2005, 7:R784-795. 10.1186/ar1733 1175027 15987480
30. Xu W He B Chiu A Chadburn A Shan M Buldys M Ding A Knowles DM Santini PA Cerutti A Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI Nat Immunol 2007, 8:294-303. 10.1038/ni1434 17259987
31. Li MO Wan YY Sanjabi S Robertson AK Flavell RA Transforming growth factor-beta regulation of immune responses Annu Rev Immunol 2006, 24:99-146. 10.1146/annurev.immunol.24.021605.090737 16551245
32. Seyler TM Park YW Takemura S Bram RJ Kurtin PJ Goronzy JJ Weyand CM BLyS and APRIL in rheumatoid arthritis J Clin Invest 2005, 115:3083-3092. 10.1172/JCI25265 1257539 16239971